Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LOMITAPIDE vs LORAZEPAM: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LOMITAPIDE vs LORAZEPAM: Safety Overview

Metric LOMITAPIDE LORAZEPAM
Total FAERS Reports 3,779 33,404
Deaths Reported 109 6,187
Death Rate 2.9% 18.5%
Hospitalizations 434 15,431
Average Patient Age 54.6 yrs 49.8 yrs
% Female Patients 66.5% 60.8%
FDA Approval Date Apr 23, 2015 Approved Prior to Jan 1, 1982
Manufacturer Amryt Pharmaceuticals DAC Hikma Pharmaceuticals USA Inc.
Route ORAL INTRAMUSCULAR
Marketing Status Prescription Prescription